BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3113970)

  • 21. Digoxin-quinidine interaction in patients with chronic renal failure.
    Fenster PE; Hager WD; Perrier D; Powell JR; Graves PE; Michael UF
    Circulation; 1982 Dec; 66(6):1277-80. PubMed ID: 7139903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinidine and digoxin. An important interaction.
    Bigger JT; Leahey EB
    Drugs; 1982 Sep; 24(3):229-39. PubMed ID: 6751790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of quinidine on digoxin bioavailability.
    Pedersen KE; Christiansen BD; Klitgaard NA; Nielsen-Kudsk F
    Eur J Clin Pharmacol; 1983; 24(1):41-7. PubMed ID: 6832200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by basic drugs of digoxin secretion into human bile.
    Hedman A
    Eur J Clin Pharmacol; 1992; 42(4):457-9. PubMed ID: 1516611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinidine-digoxin interaction: evidence for involvement of an extrarenal mechanism.
    Doering W; Fichtl B; Herrmann M; Besenfelder E
    Eur J Clin Pharmacol; 1982; 21(4):281-5. PubMed ID: 7056272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digoxin-quinidine interaction in patients with renal failure.
    Hirschberg R; Schaefer K; von Herrath D; Kreutz G; Kewitz H
    Klin Wochenschr; 1981 May; 59(10):521-2. PubMed ID: 7241953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinidine-digoxin interaction: time course and pharmacokinetics.
    Leahey EB; Bigger JT; Butler VP; Reiffel JA; O'Connell GC; Scaffidi LE; Rottman JN
    Am J Cardiol; 1981 Dec; 48(6):1141-6. PubMed ID: 7304462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digoxin-quinidine-spironolactone interaction.
    Fenster PE; Hager WD; Goodman MM
    Clin Pharmacol Ther; 1984 Jul; 36(1):70-3. PubMed ID: 6734052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digoxin bioavailability during quinidine administration.
    Hager WD; Mayersohn M; Graves PE
    Clin Pharmacol Ther; 1981 Nov; 30(5):594-9. PubMed ID: 7297019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of the digoxin-quinidine and digoxin-verapamil interactions in the rat kidney.
    Koren G; MacLeod SM
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):3-18. PubMed ID: 6473899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of quinidine on digoxin concentration in skeletal muscle and serum in patients with atrial fibrillation. Evidence for reduced binding of digoxin in muscle.
    Schenck-Gustafsson K; Jogestrand T; Nordlander R; Dahlqvist R
    N Engl J Med; 1981 Jul; 305(4):209-11. PubMed ID: 7242601
    [No Abstract]   [Full Text] [Related]  

  • 32. Impairment of digoxin clearance by coadministration of quinidine.
    Ochs HR; Bodem G; Greenblatt DJ
    J Clin Pharmacol; 1981 Oct; 21(10):396-400. PubMed ID: 7309901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliary excretion studies with digoxin in man.
    Klotz U; Antonin KH
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):332-4. PubMed ID: 892949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digoxin-quinidine interaction: in vitro studies in rat tissue.
    Kaplinsky C; Aladjem M; Wolfish N; Laufer J; Halkin H
    J Lab Clin Med; 1980 Oct; 96(4):592-6. PubMed ID: 7419952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No effect of probenecid on the renal and biliary clearances of digoxin in man.
    Hedman A; Angelin B; Arvidsson A; Dahlqvist R
    Br J Clin Pharmacol; 1991 Jul; 32(1):63-7. PubMed ID: 1888643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of quinine on digoxin kinetics.
    Wandell M; Powell JR; Hager WD; Fenster PE; Graves PE; Conrad KA; Goldman S
    Clin Pharmacol Ther; 1980 Oct; 28(4):425-30. PubMed ID: 7408402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of quinidine and disopyramide on serum digoxin concentrations.
    Manolas EG; Hunt D; Sloman G
    Aust N Z J Med; 1980 Aug; 10(4):426-9. PubMed ID: 6932834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in steady state digoxin pharmacokinetics during quinidine therapy in cardiac patients: influence of plasma quinidine concentration.
    Pedersen KE; Christiansen BD; Klitgaard NA; Nielsen-Kudsk F
    Acta Pharmacol Toxicol (Copenh); 1983 May; 52(5):357-63. PubMed ID: 6880771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic interaction between quinidine and digoxin: role of inhibition of sinusoidal Na⁺/K⁺ ATPase digoxin binding.
    Li P; Weiss M; Roberts MS
    Eur J Pharm Sci; 2012 Sep; 47(2):506-11. PubMed ID: 22820029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinidine-induced changes in serum and skeletal muscle digoxin concentration; evidence of saturable binding of digoxin to skeletal muscle.
    Jogestrand T; Schenck-Gustafsson K; Nordlander R; Dahlqvist R
    Eur J Clin Pharmacol; 1984; 27(5):571-5. PubMed ID: 6519162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.